查看购物车
  • Traditional Chinese
  • English
DNA 质粒製造市场规模及预测 2021 - 2031、全球及地区份额、趋势及成长机会分析报告涵盖范围：按产品类型、应用、最终用户和地理划分
市场调查报告书
商品编码
1761175

DNA 质粒製造市场规模及预测 2021 - 2031、全球及地区份额、趋势及成长机会分析报告涵盖范围：按产品类型、应用、最终用户和地理划分

DNA Plasmid Manufacturing Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User and Geography
出版日期: | 出版商: The Insight Partners | 英文 222 Pages | 订单完成后即时交付

价格

DNA质粒製造市场预计将从2024年的6.8638亿美元增至2031年的26.4836亿美元；预计2025-2031年期间的复合年增长率将达到21.4%。推动市场成长的主要因素包括基因治疗质粒研发的不断增加以及DNA质粒疫苗研发的持续深入。然而，高昂的製造成本是阻碍市场发展的因素之一。

遗传疾病、孤儿疾病和其他癌症的发生率上升加速了基因治疗技术的进步，而基因治疗技术主要以质粒DNA为基本元件。质粒DNA有助于将遗传物质引入患者细胞。它作为一种非病毒载体，递送治疗基因，从而修復或替换缺陷基因。与病毒载体不同，质粒更安全、更容易生产且成本更低，因此在基因治疗中广受欢迎。

随着基因疗法从临床前开发阶段过渡到临床试验和商业化上市，对大量高纯度、GMP 级质粒 DNA 的需求显着增长。 2023 年 3 月，Charles River Laboratories International, Inc. 宣布推出其现成的 pHelper（辅助质粒）产品，旨在确保供应，并简化基于腺相关病毒 (AAV) 的基因治疗项目从早期发现到商业化生产的整个流程。

不断拓展公司间的合作关係，以满足基因治疗产品线的品质和监管需求。 2022年，Myrtelle 和 Forge Biologics 宣布建立病毒载体和质粒 DNA cGMP 生产合作伙伴关係。 Forge 将为 Myrtelle 的 Myr-201 计画（用于治疗单基因听力损失的新型基因疗法）提供研究级和 GMP-Pathway 质粒生产服务，以及 cGMP 腺相关病毒 (AAV) 製程开发和规模化生产服务。

政府和监管机构也透过加快基因治疗产品的审批和国家生物技术基础设施投资来推动这一趋势。 VGXI公司最近在其位于德克萨斯州康罗的GMP工厂成功通过了FDA检查。此检查促成了客户生物製品许可证申请(BLA)的批准。 VGXI的成就巩固了其作为质粒DNA製造领导者的信誉，并凸显了其在商业化阶段基因疗法、DNA疫苗和RNA药物方面的重要性。

DNA质粒市场正从一条专业研究供应链转型为当代治疗发展的重要支柱。因此，基因治疗质粒的蓬勃发展推动了DNA质粒製造市场的发展。

比较公司分析基于产品组合（产品满意度、产品特性和可用性）、近期市场发展（併购、新产品发布和改进、投资和融资、奖项、协议、合作与伙伴关係、认可和扩张）以及地理位置，对 DNA 质粒製造市场进行评估和分类，以帮助企业更好地做出决策并了解竞争格局。该报告深入探讨了全球 DNA 质粒製造市场领先供应商近期的重大发展和创新。主要的市场参与者包括药明生物製药公司、Charles River Laboratories International Inc、康泰伦特公司、赛默飞世尔科技公司、AGC Biologics AS、宝生物株式会社、SK pharmteco Inc、赛多利斯公司、Creative Biogene 和金斯瑞生物科技公司。

根据产品类型，DNA 质粒製造市场分为 GMP 级和研发级。 GMP 级细分市场在 2024 年占据 DNA 质粒製造市场的最大份额，预计在 2024-2031 年期间将实现最高复合年增长率。根据应用，DNA 质粒製造市场细分为细胞和基因治疗、DNA 疫苗、免疫治疗和其他。 2024 年，细胞和基因治疗细分市场占据最大的市场份额。根据最终用户，DNA 质粒製造市场细分为製药和生物技术公司、合约研究组织 (CRO) 和合约研发生产组织 (CDMO) 以及其他。 2024 年，製药和生技公司细分市场占据最大的市场。

DNA质粒製造市场的公司采用各种有机和无机成长策略。有机成长策略主要包括产品发布和产品批准。市场上常见的无机成长策略包括收购、合作和伙伴关係。这些成长策略使市场参与者能够扩展业务，增强地域影响力，并促进整体市场成长。此外，收购和伙伴关係等策略有助于巩固客户群并扩展产品组合。以下列出了DNA质粒製造市场主要参与者的一些重要进展。

2025年3月，药明生物推出EffiX微生物表现平台，协助重组蛋白及质粒DNA生产。 EffiX旨在满足业界对高产量、稳定、非溶源性大肠桿菌表达系统的需求。该平台为全球客户开发和生产非单株抗体（non-mAb）重组蛋白和质粒DNA提供全面的解决方案。 EffiX可在多种生产模式下达到高产量，非mAb重组蛋白的滴度超过15 g/L，质粒DNA的滴度超过1 g/L。

目录

第一章：简介

第二章：执行摘要

  • 分析师市场展望

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：
  • 假设和局限性

第四章：DNA质粒製造市场格局

  • PEST分析

第五章：DNA质粒製造市场－关键市场动态

  • DNA质粒製造市场－关键市场动态
  • 市场驱动因素
    • 增加质粒的基因治疗开发
    • DNA质粒疫苗研发研究日益活跃
  • 市场限制
    • 製造成本高
  • 市场机会
    • 合约开发和製造组织 (CDMO) 的扩张
  • 未来趋势
    • 数位技术在质粒DNA製造中的整合
  • 驱动因素和限制因素的影响：

第六章：DNA质粒製造市场-全球市场分析

  • DNA质粒製造市场收入（2021-2031）
  • DNA质粒製造市场预测分析

第七章：DNA质粒製造市场分析－依产品类型

  • GMP级
  • 研发级

第 8 章：DNA 质粒製造市场分析 - 按应用

  • 细胞和基因治疗
  • DNA疫苗
  • 免疫疗法
  • 其他的

第九章：DNA质粒製造市场分析－依最终用户

  • 製药和生物技术公司
  • CRO 和 CDMO
  • 其他的

第 10 章：DNA 质粒製造市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：竞争格局

  • 关键参与者的热图分析
  • 2024年公司市占率分析

第 12 章：产业格局

  • 概述
  • 尼日利亚传染病体外诊断市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十三章：公司简介

  • Sartorius AG
  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Thermo Fisher Scientific Inc.
  • AGC Biologics AS
  • Takara Bio Inc
  • Creative Biogene
  • SK Pharmteco Inc
  • GenScript Biotech Corporation

第 14 章：附录

Product Code: TIPRE00021640

The DNA plasmid Manufacturing Market is expected to reach US$ 2,648.36 Mn by 2031 from US$ 686.38 Mn in 2024; the market is estimated to grow at a CAGR of 21.4% during 2025-2031. Major factors driving the market growth include increasing plasmid developments for gene therapy and growing research on DNA plasmid vaccine development. However, high manufacturing costs among the market deterrents.

The rise in the prevalence of genetic diseases, orphan diseases, and other cancers has accelerated the advancement of gene therapy technologies, which are based largely on plasmid DNA as the fundamental element. Plasmid DNA helps introduce genetic material into patients' cells. It acts as a non-viral vector to deliver therapeutic genes that can fix or replace faulty genes. Unlike viral vectors, plasmids are safer, easier to produce, and cheaper, making them popular in gene therapy.

As gene therapies transition from preclinical development to clinical trials and commercial launch, the demand for substantial quantities of high-purity, GMP-grade plasmid DNA has escalated significantly. In March 2023, Charles River Laboratories International, Inc. announced the launch of its off-the-shelf pHelper (Helper Plasmid) offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing.

Growing partnerships between companies to meet the quality and regulatory demands of gene therapy pipelines. In 2022, Myrtelle and Forge Biologics announced a viral vector and plasmid DNA cGMP manufacturing partnership. Forge will provide research-grade and GMP-Pathway plasmid manufacturing services as well as cGMP adeno-associated viral (AAV) process development and scale-up manufacturing services for Myrtelle's program, Myr-201 (novel gene therapy for monogenic hearing loss).

Governments and regulatory agencies are also helping to drive this trend with expedited approvals for gene therapy products and national biotech infrastructure investment. VGXI, Inc. recently completed a successful FDA inspection at its GMP facility in Conroe, Texas. This inspection led to the approval of a client's Biologics License Application (BLA). VGXI's achievement reinforces its credibility as a plasmid DNA manufacturing leader as well as underscores its importance in enabling commercial-stage gene therapies, DNA vaccines, and RNA-based medicines.

The DNA plasmid market is transforming from a specialized research supply chain to an essential backbone of contemporary therapeutic development. Therefore, the increasing development of plasmid for gene therapy drives the DNA plasmid manufacturing market.

The comparative company analysis evaluates and categorizes the DNA plasmid Manufacturing Market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global DNA plasmid Manufacturing Market. The key market players are WuXi Biologics Inc, Charles River Laboratories International Inc, Catalent Inc, Thermo Fisher Scientific Inc., AGC Biologics AS, Takara Bio Inc, SK pharmteco Inc, Sartorius, Creative Biogene, GenScript Biotech Corporation

The DNA plasmid Manufacturing Market, based on product type, is divided into GMP Grade and R&D grade. The GMP Grade segment held the largest share of the DNA plasmid Manufacturing Market in 2024, and it is expected to register the highest CAGR during 2024-2031. Based on Application, the DNA plasmid Manufacturing Market is segmented into Cell and Gene Therapy, DNA Vaccines, Immunotherapy, and Others. In 2024, the cell and gene therapy segment held the largest share of the market. Based on end user, the DNA plasmid Manufacturing Market is segmented into Pharmaceutical and Biotechnology Companies, CROs and CDMOs and Others. In 2024, the Pharmaceutical and Biotechnology Companies segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the DNA plasmid Manufacturing Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the DNA plasmid Manufacturing Market are listed below.

In March 2025, WuXi Biologics Launched EffiX Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production. EffiX is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for developing and manufacturing non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the globe. EffiX delivers high-yield production across multiple modalities, achieving titers of over 15 g/L for non-mAb recombinant proteins and over 1 g/L for plasmid DNA.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. DNA Plasmid Manufacturing Market Landscape

  • 4.1 PEST Analysis

5. DNA Plasmid Manufacturing Market - Key Market Dynamics

  • 5.1 DNA Plasmid Manufacturing Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Plasmid Developments for Gene Therapy
    • 5.2.2 Growing Research on DNA Plasmid Vaccine Development
  • 5.3 Market Restraints
    • 5.3.1 High Manufacturing Costs
  • 5.4 Market Opportunities
    • 5.4.1 Expansion of Contract Development and Manufacturing Organizations (CDMOs)
  • 5.5 Future Trends
    • 5.5.1 Integration of Digital Technologies in Plasmid DNA Manufacturing
  • 5.6 Impact of Drivers and Restraints:

6. DNA Plasmid Manufacturing Market - Global Market Analysis

  • 6.1 DNA Plasmid Manufacturing Market Revenue (US$ Million), 2021-2031
  • 6.2 DNA Plasmid Manufacturing Market Forecast Analysis

7. DNA Plasmid Manufacturing Market Analysis - by Product Type

  • 7.1 GMP Grade
    • 7.1.1 Overview
    • 7.1.2 GMP Grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 R&D grade
    • 7.2.1 Overview
    • 7.2.2 R&D grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

8. DNA Plasmid Manufacturing Market Analysis - by Application

  • 8.1 Cell and Gene Therapy
    • 8.1.1 Overview
    • 8.1.2 Cell and Gene Therapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 DNA Vaccines
    • 8.2.1 Overview
    • 8.2.2 DNA Vaccines: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Immunotherapy
    • 8.3.1 Overview
    • 8.3.2 Immunotherapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

9. DNA Plasmid Manufacturing Market Analysis - by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical and Biotechnology Companies: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 CROs and CDMOs
    • 9.2.1 Overview
    • 9.2.2 CROs and CDMOs: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

10. DNA Plasmid Manufacturing Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America DNA Plasmid Manufacturing Market Overview
    • 10.2.2 North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.2.3 North America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.2.3.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.2.4 North America: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.2.4.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.5.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.2.1 United States: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.2.2 United States: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.2.3 United States: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.6.3 Canada: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.3.1 Canada: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.3.2 Canada: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.3.3 Canada: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.2.6.4 Mexico: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.4.1 Mexico: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.2.6.4.2 Mexico: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe DNA Plasmid Manufacturing Market Overview
    • 10.3.2 Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.3.3 Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.3.3.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.3.4 Europe: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.3.4.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.5.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.2.1 Germany: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.2.2 Germany: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.2.3 Germany: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.3 United Kingdom: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.3.1 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.3.2 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.3.3 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.4 France: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.4.1 France: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.4.2 France: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.4.3 France: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.5 Italy: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.5.1 Italy: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.5.2 Italy: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.5.3 Italy: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.6 Spain: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.6.1 Spain: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.6.2 Spain: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.6.3 Spain: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.3.6.7 Rest of Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.3.6.7.2 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific DNA Plasmid Manufacturing Market Overview
    • 10.4.2 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.4.3 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.4.3.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.4.4 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.4.5 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.5.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.4.6 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.2 China: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.2.1 China: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.2.2 China: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.2.3 China: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.3 Japan: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.3.1 Japan: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.3.2 Japan: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.3.3 Japan: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.4 India: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.4.1 India: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.4.2 India: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.4.3 India: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.5 Australia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.5.1 Australia: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.5.2 Australia: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.5.3 Australia: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.6 South Korea: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.6.1 South Korea: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.6.2 South Korea: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.6.3 South Korea: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.4.6.7 Rest of APAC: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.6.7.1 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.4.6.7.2 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.4.6.7.3 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa DNA Plasmid Manufacturing Market Overview
    • 10.5.2 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.5.3 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.5.3.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.5.4 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.5.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.2.1 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.2.2 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.3 South Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.3.1 South Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.3.2 South Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.4 United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.4.2 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.5.6.5 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.5.6.5.2 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America DNA Plasmid Manufacturing Market Overview
    • 10.6.2 South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
    • 10.6.3 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
      • 10.6.3.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
    • 10.6.4 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application
      • 10.6.4.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.5.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.2.1 Brazil: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.2.2 Brazil: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.6.3 Argentina: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.3.1 Argentina: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.3.2 Argentina: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: DNA Plasmid Manufacturing Market Breakdown, by End User
      • 10.6.6.4 Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
        • 10.6.6.4.2 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Market Share Analysis, 2024

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Sartorius AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 WuXi Biologics Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Charles River Laboratories International Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Catalent Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 AGC Biologics AS
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Takara Bio Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
  • 13.8 Creative Biogene
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 SK Pharmteco Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 GenScript Biotech Corporation
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. DNA Plasmid Manufacturing Market Segmentation
  • Table 2. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 5. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 6. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 9. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 10. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 11. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 12. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 13. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 14. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 17. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 18. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 19. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 20. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 21. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 22. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 23. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 24. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 25. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 26. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 27. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 28. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 29. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 30. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 31. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 32. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 33. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 34. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 35. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 36. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 37. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 38. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 39. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 40. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 41. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 42. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 43. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 44. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 45. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 46. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 47. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 48. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 49. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 50. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 51. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 52. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 53. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 54. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 55. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 56. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 57. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 58. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 59. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 61. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 62. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 63. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 64. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 65. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 66. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 67. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 68. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 69. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 70. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 71. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 72. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 73. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 74. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 75. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 76. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 77. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 78. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 81. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 82. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 83. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 84. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 85. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 86. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 87. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 88. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 89. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 90. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 91. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 92. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 93. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 94. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 95. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 96. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 97. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 98. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 99. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 100. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 101. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 102. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 103. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 104. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 105. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 106. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 107. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 108. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 109. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 110. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 113. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 114. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 115. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 116. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 117. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 118. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 119. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 120. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 121. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 122. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 123. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 124. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 125. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 126. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 127. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 128. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 129. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 130. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 131. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 132. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 133. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 134. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 135. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 136. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 137. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 138. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 139. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 140. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 141. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 142. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 143. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 144. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 145. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 146. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 147. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 148. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 149. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 150. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 151. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 152. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 153. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 154. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 155. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 156. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 157. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 158. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 159. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 160. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 161. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 162. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 163. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 164. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 165. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 166. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 167. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 168. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 169. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 170. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 171. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 172. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 173. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 174. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 175. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 176. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 177. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 178. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 179. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 180. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 181. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 182. Heat Map Analysis by Key Players
  • Table 183. Recent Organic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • Table 184. Recent Inorganic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
  • Table 185. Glossary of Terms, Infectious Disease Diagnostics Market

List Of Figures

  • Figure 1. DNA Plasmid Manufacturing Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. DNA Plasmid Manufacturing Market Revenue (US$ Million), 2021-2031
  • Figure 5. DNA Plasmid Manufacturing Market Share (%) - by Product Type (2024 and 2031)
  • Figure 6. GMP Grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. R&D grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. DNA Plasmid Manufacturing Market Share (%) - by Application (2024 and 2031)
  • Figure 9. Cell and Gene Therapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. DNA Vaccines: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Immunotherapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. DNA Plasmid Manufacturing Market Share (%) - by End User (2024 and 2031)
  • Figure 14. Pharmaceutical and Biotechnology Companies: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. CROs and CDMOs: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. DNA Plasmid Manufacturing Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 18. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 19. North America: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 20. North America: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 21. North America: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 22. North America: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 23. United States: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Canada: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Mexico: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 27. Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 28. Europe: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 29. Europe: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 30. Europe: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. Germany: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. United Kingdom: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. France: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Italy: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Spain: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 38. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 39. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 40. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 41. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 42. China: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Japan: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. India: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. Australia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. South Korea: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 49. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 50. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 51. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 52. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 53. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. South Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 56. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 58. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
  • Figure 59. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
  • Figure 60. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
  • Figure 61. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 62. Brazil: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 63. Argentina: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 64. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 65. Company Market Share Analysis, 2024
  • Figure 66. Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market